Damon R. Reed

9.6k total citations
158 papers, 3.8k citations indexed

About

Damon R. Reed is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Damon R. Reed has authored 158 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in Damon R. Reed's work include Sarcoma Diagnosis and Treatment (71 papers), Childhood Cancer Survivors' Quality of Life (26 papers) and Cancer Genomics and Diagnostics (21 papers). Damon R. Reed is often cited by papers focused on Sarcoma Diagnosis and Treatment (71 papers), Childhood Cancer Survivors' Quality of Life (26 papers) and Cancer Genomics and Diagnostics (21 papers). Damon R. Reed collaborates with scholars based in United States, Canada and United Kingdom. Damon R. Reed's co-authors include Gwendolyn P. Quinn, Marilyn M. Bui, Andrew S. Brohl, Ivana Sehovic, Anthony P. Conley, Meghan Bowman, Vânia Gonçalves, Soner Altiok, Elliot Kahen and Jenny Kreahling and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Damon R. Reed

152 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damon R. Reed United States 32 1.4k 1.2k 971 656 527 158 3.8k
Maura Massimino Italy 41 1.0k 0.8× 1.7k 1.4× 1.5k 1.5× 1.1k 1.7× 523 1.0× 346 6.2k
Abha A. Gupta Canada 38 1.2k 0.9× 1.5k 1.2× 737 0.8× 1.1k 1.6× 780 1.5× 241 5.0k
Roberto Luksch Italy 38 918 0.7× 1.3k 1.0× 1.4k 1.5× 516 0.8× 269 0.5× 189 4.5k
Joel I. Sorosky United States 43 1.9k 1.4× 838 0.7× 881 0.9× 342 0.5× 413 0.8× 156 6.5k
Stewart Goldman United States 48 903 0.7× 1.2k 0.9× 2.4k 2.5× 611 0.9× 594 1.1× 178 6.7k
Florence Joly France 50 2.8k 2.1× 3.3k 2.6× 1.0k 1.0× 589 0.9× 364 0.7× 330 7.9k
M. Fatih Okcu United States 38 723 0.5× 1.6k 1.3× 817 0.8× 871 1.3× 585 1.1× 148 3.8k
François Doz France 52 1.8k 1.3× 2.0k 1.6× 2.2k 2.3× 1.1k 1.7× 587 1.1× 324 8.3k
Robert A. Gardiner Australia 40 1.7k 1.2× 2.3k 1.8× 1.1k 1.1× 333 0.5× 317 0.6× 182 5.5k
Ingrid Glimelius Sweden 30 1.7k 1.3× 638 0.5× 355 0.4× 612 0.9× 484 0.9× 181 3.6k

Countries citing papers authored by Damon R. Reed

Since Specialization
Citations

This map shows the geographic impact of Damon R. Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damon R. Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damon R. Reed more than expected).

Fields of papers citing papers by Damon R. Reed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damon R. Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damon R. Reed. The network helps show where Damon R. Reed may publish in the future.

Co-authorship network of co-authors of Damon R. Reed

This figure shows the co-authorship network connecting the top 25 collaborators of Damon R. Reed. A scholar is included among the top collaborators of Damon R. Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damon R. Reed. Damon R. Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenzang, Katie A., Kathleen Montgomery, Adam DuVall, et al.. (2025). Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. JNCI Journal of the National Cancer Institute. 117(9). 1764–1773.
2.
Gundem, Gunes, Chad Vanderbilt, Leonard H. Wexler, et al.. (2025). Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult Counterparts. Modern Pathology. 38(8). 100769–100769.
3.
McGuire, Jeremy, et al.. (2024). Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Letters. 606. 217302–217302. 8 indexed citations
4.
Shulman, David S., Kelly Klega, Allen Buxton, et al.. (2024). Association of elevated ctDNA burden following one cycle of chemotherapy with inferior outcomes for patients with metastatic Ewing sarcoma: A report from the Children’s Oncology Group (COG).. Journal of Clinical Oncology. 42(16_suppl). 10018–10018. 1 indexed citations
5.
Robinson, Lary A., Tawee Tanvetyanon, Sandra C. Bryant, et al.. (2024). Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A 25-Year Experience. Clinical Lung Cancer. 25(6). 537–549.e2. 1 indexed citations
6.
Kelly, Ciara M., Mary Louise Keohan, Jason E. Chan, et al.. (2024). 1752P A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma. Annals of Oncology. 35. S1045–S1045. 1 indexed citations
7.
Reed, Damon R., et al.. (2023). Trends in Overall Survival among Patients Treated for Sarcoma at a Large Tertiary Cancer Center between 1986 and 2014. Cancers. 15(2). 514–514. 4 indexed citations
8.
Weiss, Aaron R., Safia K. Ahmed, Wendy Allen‐Rhoades, et al.. (2023). Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group. Journal of Adolescent and Young Adult Oncology. 12(5). 792–793. 1 indexed citations
9.
Roth, Michael, Damon R. Reed, Aaron R. Weiss, et al.. (2023). Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology. Pediatric Blood & Cancer. 70(S6). e30564–e30564. 6 indexed citations
10.
Crowder, Sylvia L., et al.. (2023). The Lived Experience of Young Adult Cancer Survivors after Treatment: A Qualitative Study. Nutrients. 15(14). 3145–3145. 8 indexed citations
11.
Cash, Thomas F., Mark Krailo, Allen Buxton, et al.. (2023). Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. Journal of Clinical Oncology. 41(30). 4724–4728. 6 indexed citations
12.
Fridley, Brooke L., et al.. (2022). Pilot Study in Investigating Material Financial Toxicity Markers by Age in Cancer Patients. Journal of Adolescent and Young Adult Oncology. 12(1). 34–42. 1 indexed citations
13.
Beaupin, Lynda K., et al.. (2021). Clinical Trial Availability by Location for 1000 Simulated AYA Patients. Journal of Adolescent and Young Adult Oncology. 11(1). 95–103. 3 indexed citations
14.
Reed, Damon R., Brooke L. Fridley, Masanori Hayashi, et al.. (2020). An evolutionary framework for treating pediatric sarcomas. Cancer. 126(11). 2577–2587. 31 indexed citations
15.
Davis, Lara E., Vanessa Bolejack, Christopher W. Ryan, et al.. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. Journal of Clinical Oncology. 37(16). 1424–1431. 174 indexed citations
16.
Roberts, Ryan D., Michael M. Lizardo, Damon R. Reed, et al.. (2019). Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Cancer. 125(20). 3514–3525. 87 indexed citations
17.
Stern, Marilyn, Jennifer Bleck, Janella Hudson, et al.. (2017). Adolescent and Young Adult Patients with Cancer: Perceptions of Care. Journal of Adolescent and Young Adult Oncology. 6(4). 512–518. 12 indexed citations
18.
Dossett, Lesly A., Samir Dalia, Damon R. Reed, et al.. (2015). Clinical and pathologic predictors of survival in patients with endometrial stromal sarcoma.. 1(3). 253–261. 1 indexed citations
19.
Chawla, Sant P., Lee D. Cranmer, Brian A. Van Tine, et al.. (2014). Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma. Journal of Clinical Oncology. 32(29). 3299–3306. 122 indexed citations
20.
Reed, Damon R., et al.. (1972). OPTOMETRIC DATA CHARACTERISTICS OF MALE PRISON INMATES. Optometry and Vision Science. 49(8). 661–671. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maura Massimino Breakdown of academic impact, for papers by Abha A. Gupta Breakdown of academic impact, for papers by Roberto Luksch Breakdown of academic impact, for papers by Joel I. Sorosky Breakdown of academic impact, for papers by Stewart Goldman Breakdown of academic impact, for papers by Florence Joly Breakdown of academic impact, for papers by M. Fatih Okcu Breakdown of academic impact, for papers by François Doz Breakdown of academic impact, for papers by Robert A. Gardiner Breakdown of academic impact, for papers by Ingrid Glimelius
Rankless by CCL
2026